Off-Label Use of Dementia Meds Tied to Lower Mortality in DLB
Off-label use of acetylcholinesterase inhibitors and memantine is associated with better survival following hospitalization for patients with dementia with Lewy bodies (DLB).
Stay updated with breaking news from Off Label Indication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Off-label use of acetylcholinesterase inhibitors and memantine is associated with better survival following hospitalization for patients with dementia with Lewy bodies (DLB).
Use of pimavanserin was associated with 35% lower mortality for patients with Parkinson's disease–related psychosis compared with atypical antipsychotics, a large new real-world analysis shows.
The agency continues to warn against using the Renuvion/J-Plasma system for skin contraction alone or in combination with liposuction, citing 'potentially life-threatening' adverse events.
Frequently used off-label, the drug was not riskier than placebo, a new study found.
Adverse events that have been reported include second- and third-degree burns, infections, changes in skin color, and significant bleeding.